Francesca Piaggio

Francesca Piaggio

Auto-generated profile, based on publicly available information

Francesca Piaggio

Laboratorio di Oncologia, Istituto G. Gaslini, Genoa, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2017 in Cancer and Metastasis Reviews
Verified
Journal Article
Open access
PDF file
AAAdriana Agnese Amaro
Adriana Agnese Amaro
RGRosaria Gangemi
Rosaria Gangemi
FPFrancesca Piaggio
Francesca Piaggio
GAGiovanna Angelini
Giovanna Angelini
GBGaia Barisione
Gaia Barisione
Ulrich PfefferUlrich Pfeffer
Ulrich Pfeffer
Uveal melanoma (UM), a rare cancer of the eye, is distinct from cutaneous melanoma by its etiology, the mutation frequency and profile, and its clinical behavior including resistance to targeted therapy and immune checkpoint blockers. Primary disease is efficiently controlled by surgery or radiation therapy, but about half of UMs develop distant metastasis mostly to the liver. Survival of patients with metastasis is below 1 year and has not improved in decades. Recent years have brought a deep understanding of UM biology characterized by initiating mutations in the G proteins GNAQ and GNA11. Cytogenetic alterations, in particular monosomy of chromosome 3 and amplification of the long arm of chromosome 8, and mutation of the BRCA1-associated protein 1, BAP1, a tumor suppressor gene, or the splicing factor SF3B1 determine UM metastasis. Cytogenetic and molecular profiling allow for a very precise prognostication that is still not matched by efficacious adjuvant therapies. G protein signaling has been shown to activate the YAP/TAZ pathway independent of HIPPO, and conventional signaling via the mitogen-activated kinase pathway probably also contributes to UM development and progression. Several lines of evidence indicate that inflammation and macrophages play a pro-tumor role in UM and in its hepatic metastases. UM cells benefit from the immune privilege in the eye and may adopt several mechanisms involved in this privilege for tumor escape that act even after leaving the niche. Here, we review the current knowledge of the biology of UM and discuss recent approaches to UM treatment.

1 February 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
FPF. Piaggio
F. Piaggio
Vangelis KondylisVangelis Kondylis
Vangelis Kondylis
Fabio PastorinoFabio Pastorino
Fabio Pastorino
DPD. Di Paolo
D. Di Paolo
PPPatrizia Perri
Patrizia Perri
CBChiara Brignole
Chiara Brignole

31 May 2018 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
GBGiovanna Bianchi
Giovanna Bianchi
Silvia RaveraSilvia Ravera
Silvia Ravera
CTChiara Traverso
Chiara Traverso
AAAdriana Agnese Amaro
Adriana Agnese Amaro
FPFrancesca Piaggio
Francesca Piaggio
LRLizzia Raffaghello
Lizzia Raffaghello
Curcumin has been reported to inhibit inflammation, tumor growth, angiogenesis and metastasis by decreasing cell growth and by inducing apoptosis mainly through the inhibition of nuclear factor kappa-B (NFκB), a master regulator of inflammation. Recent reports also indicate potential metabolic effects of the polyphenol, therefore we analyzed whether and how it affects the energy metabolism of tumor cells. We show that curcumin (10 µM) inhibits the activity of ATP synthase in isolated mitochondrial membranes leading to a dramatic drop of ATP and a reduction of oxygen consumption in in vitro and in vivo tumor models. The effects of curcumin on ATP synthase are independent of the inhibition of NFκB since the IκB Kinase inhibitor, SC-514, does not affect ATP synthase. The activities of the glycolytic enzymes hexokinase, phosphofructokinase, pyruvate kinase and lactate dehydrogenase are only slightly affected in a cell type-specific manner. The energy impairment translates into decreased tumor cell viability. Moreover, curcumin induces apoptosis by promoting the generation of reactive oxygen species (ROS) and malondialdehyde (MDA), a marker of lipid oxidation, and autophagy, at least in part due to the activation of the AMP-activated protein kinase (AMPK). According to the in vitro anti-tumor effect, curcumin (30 mg/kg body weight) significantly delayed in vivo cancer growth likely due to an energy impairment but also through the reduction of tumor angiogenesis. These results establish the ATP synthase, a central enzyme of the cellular energy metabolism, as a target of the antitumoral polyphenol leading to inhibition of cancer cell growth and a general reprogramming of tumor metabolism.

1 August 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
GZGuendalina Zuccari
Guendalina Zuccari
AMAndrea Milelli
Andrea Milelli
Fabio PastorinoFabio Pastorino
Fabio Pastorino
MLMonica Loi
Monica Loi
APAndrea Petretto
Andrea Petretto
MPMirco Ponzoni
Mirco Ponzoni

1 November 2015 in Biomaterials
Verified
Journal Article
Closed access
ICIrene Cossu
Irene Cossu
GBGianluca Bottoni
Gianluca Bottoni
MLMonica Loi
Monica Loi
LELaura Emionite
Laura Emionite
ABAlice Bartolini
Alice Bartolini
Fabio PastorinoFabio Pastorino
Fabio Pastorino

1 October 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
MLM. Loi
M. Loi
PBP. Becherini
P. Becherini
LEL. Emionite
L. Emionite
Arianna GiacominiArianna Giacomini
Arianna Giacomini
ICI. Cossu
I. Cossu
MPMirco Ponzoni
Mirco Ponzoni